Related Experiment Video
Updated: May 10, 2026

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
Monocytopenia as a diagnostic clue to pediatric B-lymphoblastic leukemia with rare circulating blasts
Sunita Iyengar Park1, Beverly Barton Rogers
1a Children's Healthcare of Atlanta, Pathology.
Insights
Low monocyte counts in peripheral blood flow cytometry may indicate occult B-lymphoblastic leukemia (B-LL) in children with cytopenias. Further bone marrow examination is recommended if monocytes are less than 1%.
Area of Science:
- Hematology
- Pediatric Oncology
- Flow Cytometry
Background:
- B-lymphoblastic leukemia/lymphoma (B-LL) is the most common childhood cancer.
- Rarely, circulating blasts (<1%) in peripheral blood may be missed by flow cytometry, leading to false negatives.
- Cytopenias can obscure the diagnosis of B-LL.
Purpose of the Study:
- To investigate the utility of monocyte counts in diagnosing B-LL when blasts are rare in peripheral blood.
- To determine if monocyte percentage and absolute monocyte counts (AMCs) can serve as diagnostic clues for occult leukemia.
Main Methods:
- Retrospective review of B-LL patients diagnosed between Jan 2009-Dec 2011.
- Comparison of peripheral blood flow cytometry data, specifically monocyte percentages and AMCs, between B-LL patients with <1% blasts and negative controls with cytopenias.
- Analysis included 130 B-LL cases and 39 control cases.
Main Results:
- Leukemia patients with <1% blasts had significantly lower monocyte percentages (0.8% vs 7.1%, p<0.001) compared to controls.
- 79% of leukemia patients had monocytes <1%, versus 8% in controls.
- Absolute monocyte counts (AMCs) were significantly lower in leukemia patients (93% <100 cells/µL vs 28% in controls, p<0.001).
Conclusions:
- Low monocyte percentage (<1%) and low AMCs in peripheral blood can be indicators of occult B-LL in children with cytopenias.
- Acquiring more than 10,000 events in flow cytometry is crucial for adequate blast assessment.
- If monocytes are <1% by flow cytometry in the context of cytopenias, bone marrow examination is recommended despite negative peripheral blood flow cytometry results.
Abstract:
Abstract Background: B-lymphoblastic leukemia/lymphoma (B-LL) is the most common childhood cancer. Occasionally, circulating blasts in the peripheral blood are rare ({less than or equal to}1%) and may be missed, even when flow cytometric immunophenotyping is performed, leading to a false negative report. Methods: The records from all patients with a new diagnosis of B-LL at our institution were reviewed from Jan 2009-Dec 2011. Of 130 cases with peripheral blood flow cytometry, 15 had a blast count of {less than or equal to}1%, with 14 having electronic files for gating monocytes. The percentage of monocytes by flow cytometry and absolute monocyte counts (AMCs) were compared with peripheral blood samples that were negative by flow cytometry, sent due to at least one lineage cytopenia (n=39). Results: The monocytes from the patients with leukemia averaged 0.8%, and were statistically lower than the negative controls, which averaged 7.1% (p<0.001). 11 of the 14 (79%) patients with leukemia had monocytes <1%, compared to only 3 (8%) of the negative controls. The AMCs were also significantly lower (p<0.001), with 93% of the leukemia group having an AMC of <100 cells/µL, compared to only 28% of the negative controls. Conclusions: In patients presenting with cytopenias, assessment of percentage monocytes may be an important diagnostic clue in determining the presence of occult leukemia. If flow cytometry is performed, acquisition of more than the standard 10,000 events is necessary to adequately assess for leukemia. If monocytes are <1% by flow cytometry in the setting of cytopenias, bone marrow examination is recommended, even with negative peripheral blood flow cytometry.
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
08:31Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025